Utama › Jangkitan COVID-19 dan Koronavirus › California
Kajian klinikal Jangkitan COVID-19 dan Koronavirus di California
12 kajian untuk Jangkitan COVID-19 dan Koronavirus sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of California, Los Angeles (UCLA), Los Angeles
- University of California San Francisco, San Francisco
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- dan 9 lagi
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 0 hingga 20 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- UCLA Westwood, Los Angeles
- UCSF Community and Clinical Research Center, San Francisco
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 40 hingga 64 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
- Zuckerberg San Francisco General Hospital (ZSFG), San Francisco
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 100 · Semua jantina · Dikemas kini 23 Jul 2026 · NCT04362150Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- City of Hope cancer Center, Duarte
- University of California Davis Health System, Sacramento
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 23 Jun 2026 · NCT03808922Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Stanford University School of Medicine, Stanford
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 99 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT04330521Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Stanford University, Palo Alto
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 9 hingga 64 · Semua jantina · Dikemas kini 18 Mac 2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
- Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 5 Sep 2025 · NCT05868239Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.